Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1018.00    -10.00 (-0.97%)
Bid:
1024.00
Ask:
1026.00
Spread: 2.00 (0.195%)
Market Cap: £146.08b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Buyback programme: transactions 28Aug-3Sept

4 Sep 2025 11:04

RNS Number : 0499Y
Banco Santander S.A.
04 September 2025
 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

Reference is made to our notice of inside information of 30 July 2025 (official registry number 2844) (the "Buyback Commencement Communication"), relating to the buyback programme of own shares (the "Buyback Programme") approved by the Board of Directors of Banco Santander.

 

Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs of the transactions carried out over its own shares between 28 August and 3 September 2025 (both inclusive).

 

The cash amount of the shares purchased to 3 September 2025 as a result of the execution of the Buyback Programme amounts to 341,234,794 Euros, which represents approximately 20.1% of the maximum investment amount of the Buyback Programme. The programme was announced together with its other characteristics through the Buyback Commencement Communication. With these purchases, the Bank has repurchased approximately 14.4% of its outstanding shares as of 2021.

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

28/08/2025

SAN

Purchase

XMAD

361,710

8.2110

28/08/2025

SAN

Purchase

CEUX

27,941

8.2083

28/08/2025

SAN

Purchase

TQEX

18,829

8.1820

28/08/2025

SAN

Purchase

AQEU

14,955

8.1776

29/08/2025

SAN

Purchase

XMAD

1,050,115

8.1150

29/08/2025

SAN

Purchase

CEUX

136,427

8.0983

29/08/2025

SAN

Purchase

TQEX

43,516

8.1219

29/08/2025

SAN

Purchase

AQEU

19,942

8.0981

01/09/2025

SAN

Purchase

XMAD

510,578

8.1539

01/09/2025

SAN

Purchase

CEUX

100,488

8.1493

01/09/2025

SAN

Purchase

TQEX

38,750

8.1496

01/09/2025

SAN

Purchase

AQEU

50,184

8.1524

02/09/2025

SAN

Purchase

XMAD

1,230,000

8.0827

02/09/2025

SAN

Purchase

CEUX

454,077

8.0379

02/09/2025

SAN

Purchase

TQEX

125,179

8.0454

02/09/2025

SAN

Purchase

AQEU

190,744

8.0453

03/09/2025

SAN

Purchase

XMAD

833,728

8.0462

03/09/2025

SAN

Purchase

CEUX

84,308

8.0558

03/09/2025

SAN

Purchase

TQEX

34,792

8.0369

03/09/2025

SAN

Purchase

AQEU

47,172

8.0623

TOTAL

5,373,435

 

 

 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

 

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

Detailed information of the transactions carried out within the referred period is attached as Annex I.

 

Boadilla del Monte (Madrid), 4 September 2025

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 28/08/2025 and 03/09/2025 (both inclusive)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSSDFSLEISESU
Date   Source Headline
19th Feb 20247:43 amRNSDividend approval & buyback program implementation
7th Feb 20244:39 pmRNSDirector/PDMR Shareholding
7th Feb 20244:38 pmRNSDirector/PDMR Shareholding
7th Feb 20244:36 pmRNSDirector/PDMR Shareholding
5th Feb 20245:48 pmRNSFurther re capital reduction
1st Feb 20244:46 pmRNSDirector/PDMR Shareholding
31st Jan 20243:55 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNS2023 Results - Press release
31st Jan 20247:00 amRNS2023 Results Report & Earnings Presentation
26th Jan 202411:32 amRNSCapital reduction following completion of program
26th Jan 202411:19 amRNSTransaction in Own Shares
24th Jan 202411:06 amRNSNotice of 2023 Results Presentation
18th Jan 202411:05 amRNSBuyback programme: transactions 11-17 Jan
11th Jan 202411:08 amRNSBuyback programme: transactions 4-10 Jan
4th Jan 202411:07 amRNSBuyback programme: transactions 28 Dec- 3 Jan
29th Dec 202311:58 amRNSTotal Voting Rights
28th Dec 202311:08 amRNSBuyback programme: transactions 21-27 Dec
21st Dec 202311:07 amRNSBuyback programme: transactions 14-20 Dec
20th Dec 20234:14 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSAdapting reporting to new operating model (ppt)
20th Dec 20237:00 amRNSAdapting reporting to new operating model (PR)
18th Dec 20235:22 pmRNSDirector/PDMR Shareholding
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec
13th Dec 20234:41 pmRNSDirector/PDMR Shareholding
13th Dec 20237:02 amRNSOptional early redemption ISIN XS1951093894
11th Dec 202311:24 amRNSSREP Capital Requirements 2024
5th Dec 202311:09 amRNSBuyback programme: transactions 30 Nov – 4 Dec
30th Nov 202311:18 amRNSTotal Voting Rights
30th Nov 202311:12 amRNSBuyback programme: transactions 23-29 Nov
23rd Nov 202311:07 amRNSBuyback programme: transactions 16-22 Nov
22nd Nov 20237:08 amRNSOptional early redemption ISIN XS1692931121
17th Nov 20237:00 amRNSAT1s Contingent Convertible securities
16th Nov 20232:24 pmRNSBuyback programme: transactions 8-15 Nov
16th Nov 202311:06 amRNSBuyback programme: transactions 8-15 Nov
8th Nov 202311:06 amRNSBuyback programme: transactions 31 Oct – 7 Nov
31st Oct 202312:03 pmRNSTotal Voting Rights
31st Oct 202310:14 amRNSBuyback programme: transactions 26–30 Oct
26th Oct 202312:09 pmRNSTotal Voting Rights
26th Oct 202311:05 amRNSBuyback programme: transactions 19 Oct – 25 Oct
25th Oct 20237:00 amRNS3Q 2023 Results Report & Earnings Presentation
25th Oct 20237:00 amRNS3rd Quarter 2023 Results - Press release
19th Oct 202311:08 amRNSBuyback programme: transactions 11 Oct – 18 Oct
18th Oct 202311:11 amRNSNotice of Third Quarter 2023 Results
11th Oct 202311:27 amRNSBuyback programme: transactions 5 Oct – 10 Oct
5th Oct 202311:41 amRNSBuyback programme: transactions 28 Sep – 4 Oct
29th Sep 202311:06 amRNSTotal Voting Rights
27th Sep 20236:31 pmRNSCommencement of a program to repurchase own shares
27th Sep 20237:00 amRNSFurther re dividend approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.